leadf
logo-loader
viewNEXTLEAF SOLUTIONS Ltd.

Nextleaf Solutions issues shares under the Employee Equity Participation Plan implemented in response to the coronavirus pandemic

Paul Pedersen, CEO of Nextleaf commented: "The Plan is an opportunity for us to give our hardworking team a greater opportunity to share in the upside potential of OILS"

Cannabis extraction plant
For the month of April, Nextleaf said it has issued an aggregate of 39,471 common shares at a price of $0.325 per share under the plan

Nextleaf Solutions Ltd. (CSE:OILS), Canada's most innovative cannabis extractor, announced it has issued shares under the Employee Equity Participation Plan that it implemented on April 1 in response to the coronavirus (COVID-19) pandemic to align the efforts and compensation of non-executive employees with the company's long-term business strategy.

For the month of April, Nextleaf said it has issued an aggregate of 39,471 common shares at a price of $0.325 per share under the plan.

READ: Nextleaf Solutions acquiree Nextleaf Labs signs cannabis extraction deal with Atlantic Canada producer

In a statement, Paul Pedersen, CEO of Nextleaf commented: "The Plan is an opportunity for us to give our hardworking team a greater opportunity to share in the upside potential of OILS.

“With our custom closed loop industrial-scale extraction plant commencing commercial production, and up to 25 metric tons of cannabis biomass under contract through Nextleaf Labs, it is a very exciting time for OILS.”

He added: “I am proud of my team's participation in the Plan, their belief in the long-term opportunity at Nextleaf, and commitment to building Canada's most efficient cannabis refinery!"

The group said the plan is fully voluntary and permits non-executive employees to receive common shares in the company in lieu of a portion of an employee's cash compensation. It allows the company to reduce the cash component of employee compensation and further align incentives across the team.

Nextleaf’s industrial-scale extraction plant in Greater Vancouver, British Columbia has a design capacity to process 600 kg per day of dried cannabis biomass into refined oils.

The company owns a portfolio of over 20 issued patents and 50 pending patents for the extraction, purification, and formulation of cannabinoids.

It commercializes its patent portfolio through IP licensing, and supplying THC and CBD oils through Nextleaf Labs, a Health Canada licensed standard processor.

Quick facts: NEXTLEAF SOLUTIONS Ltd.

Price: 0.185 CAD

CSE:OILS
Market: CSE
Market Cap: $22.1 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of NEXTLEAF SOLUTIONS Ltd. named herein, including the promotion by the Company of NEXTLEAF SOLUTIONS Ltd. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Nextleaf completes successful scale trials for Rapid Emulsion Technology by OILS

Nextleaf Solutions (CSE: OILS) Director of Marketing Emma Andrews joined Steve Darling from Proactive to discuss the company’s completion of their successful scale trials using their Rapid Emulsion Technology by OILS. Andrews discussed how that technology sets Nextleaf apart and how they can...

on 2/9/20

2 min read